POAI_OUT_1 [2025-03-25 07:40:23 -0400] 2138 Bytes | 588 tokens | Cum: 588 tkns (7.35% of 8k)
==========================================================================

Turbo, you got one job - predict the hottest stocks of the day -- before everyone else does! Ha! So today we're looking at Predictive Oncology (POAI) which is at 1.46 up from 1.115. So, I pulled together a bunch of data for you to look over real fast. It's still early, 7:40:21 AM on Tue Mar 25, 2025 -0400. So, what's the verdict? You're the expert!

Here's the first list of news for Predictive Oncology:

C1 - Today 07:00AM - Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary
C2 - Mar-20-25 07:00AM - Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries
C3 - Mar-03-25 09:15AM - Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology
C4 - Mar-03-25 09:15AM 09:00AM - Predictive Oncology Moves to Finalize Definitive Merger Agreement With Renovaro Biosciences
C5 - Feb-19-25 05:20PM - Predictive Oncology Closes Registered Direct Offering
C6 - Feb-19-25 05:20PM 10:10AM - Investors Eye Biotech Sector as Cancer Therapy Market Surges
C7 - Feb-19-25 05:20PM 08:00AM - Predictive Oncology Announces Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
C8 - Feb-18-25 03:41PM - Predictive Oncology (POAI) Struggles AI-Driven Drug Repurposing Breakthrough

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on Predictive Oncology (POAI)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

POAI_OUT_3 [2025-03-25 07:40:26 -0400] 1038 Bytes | 281 tokens | Cum: 871 tkns (10.89% of 8k)
==========================================================================

Showing C1 (chunk 1 of 7): C1:
**Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary**
Date: Today 07:00AM
Source: (GlobeNewswire)
URL: https://www.globenewswire.com/news-release/2025/03/25/3048582/37244/en/Predictive-Oncology-Successfully-Develops-Predictive-Models-Derived-from-Never-Before-Seen-Compounds-for-Prevalent-Cancer-Indications-Including-Breast-Colon-and-Ovary.html

March 25, 2025 07:00 ET| Source:Predictive Oncology Inc.Predictive Oncology Inc.

Company successfully developed predictive models derived from 21 unique compounds from the Natural Products Discovery Core at the University of Michigan

Tumor response models for novel compounds represent true drug discoveryusing Predictive's active machine learning platform

PITTSBURGH, March 25, 2025 (GLOBE NEWSWIRE) -- Predictive Oncology In

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

POAI_OUT_5 [2025-03-25 07:40:27 -0400] 1003 Bytes | 272 tokens | Cum: 1145 tkns (14.31% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-25T11:13:03Z - Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds...
A2 - 2025-03-25T11:18:42Z - Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds...
A3 - 2025-03-20T11:11:42Z - Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries | Taiwan News | M...
A4 - 2025-03-20T11:00:00Z - Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries...
A5 - 2025-03-20T11:16:37Z - Predictive Oncology Completes Sale of Skyline Medical Assets to DeRoyal Industries...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

POAI_OUT_7 [2025-03-25 07:40:29 -0400] 1038 Bytes | 270 tokens | Cum: 1417 tkns (17.71% of 8k)
==========================================================================

Showing A1 (chunk 1 of 8): A1:
**Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary**Date: 2025-03-25Source: {'uri': 'manilatimes.net', 'dataType': 'news', 'title': 'The Manila times'}URL: https://www.manilatimes.net/2025/03/25/tmt-newswire/globenewswire/predictive-oncology-successfully-develops-predictive-models-derived-from-never-before-seen-compounds-for-prevalent-cancer-indications-including-breast-colon-and-ovary/2079498Enthusiast Gaming to Announce Fourth Quarter and Year-End 2024 Results

Company successfully developed predictive models derived from 21 unique compounds from the Natural Products Discovery Core at the University of Michigan

Tumor response models for novel compounds represent true drug discovery using Predictive's active machine learning platform

PITTSBURGH, March 25, 2025 (GL

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

POAI_OUT_9 [2025-03-25 07:40:35 -0400] 1038 Bytes | 215 tokens | Cum: 1634 tkns (20.42% of 8k)
==========================================================================

Showing A1 (chunk 2 of 8): OBE NEWSWIRE) -- Predictive Oncology Inc. (NASDAQ: POAI), a leader in AI-driven drug discovery, announced today that it has successfully developed predictive models derived from 21 unique compounds from the Natural Products Discovery Core (NPDC) at the University of Michigan Life Sciences Institute.

Predictive Oncology, in partnership with the NPDC, recently evaluated 21 novel compounds using Predictive's active machine learning platform. The platform is used to shorten the time necessary to select drug candidates, while increasing the probability of technical success using live-cell tumor samples from its extensive biobank of frozen specimens.

The U-M Natural Products Discovery Core is home to a best-in-class library, and among one of the largest pharmaceutically viable natural products libraries in the United States, with specimens collected from biodiverse hotspots around the globe

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

POAI_OUT_11 [2025-03-25 07:40:36 -0400] 1178 Bytes | 359 tokens | Cum: 2105 tkns (26.31% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2025-03-25T11:00:00Z - Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary
B2 - 2025-02-19T15:06:00Z - Investors Eye Biotech Sector as Cancer Therapy Market Surges
B3 - 2025-01-11T15:24:00Z - SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates LBRDA, NARI, ML, POAI on Behalf of Shareholders
B4 - 2025-01-06T18:37:00Z - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Predictive Oncology Inc. (Nasdaq - POAI), SunLink Health Systems, Inc. (NYSE American - SSY), Universal Stainless & Alloy Products, Inc. (Nasdaq - USAP), Patterson Companies, Inc. (Nasdaq - PDCO)
B5 - 2025-01-06T14:15:00Z - Renovaro to Acquire Predictive Oncology in All-Stock Transaction
B6 - 2025-01-06T14:10:00Z - Predictive Oncology Announces Agreement to be Acquired by Renovaro

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

POAI_OUT_13 [2025-03-25 07:40:51 -0400] 898 Bytes | 222 tokens | Cum: 2329 tkns (29.11% of 8k)
==========================================================================

Showing B1 (chunk 1 of 1): B1:
**Predictive Oncology Successfully Develops Predictive Models Derived from Never-Before-Seen Compounds for Prevalent Cancer Indications Including Breast, Colon and Ovary**Date: Unknown DateSource: Unknown SourceURL: https://www.globenewswire.com/news-release/2025/03/25/3048582/37244/en/Predictive-Oncology-Successfully-Develops-Predictive-Models-Derived-from-Never-Before-Seen-Compounds-for-Prevalent-Cancer-Indications-Including-Breast-Colon-and-Ovary.htmlPredictive Oncology has successfully developed predictive models from 21 unique compounds provided by the University of Michigan's Natural Products Discovery Core. The models demonstrated strong tumor drug response across breast, colon, and ovary cancer types, outperforming a benchmark compound.

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

POAI_OUT_15 [2025-03-25 07:40:52 -0400] 1127 Bytes | 303 tokens | Cum: 2932 tkns (36.65% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S1 - 2025-03-20 8-K Item 1.01. Entry into a Material Definitive Agrmt.

On March 14, 2025, Predictive Oncology Inc. a Delaware corporation (Predictive Oncology or the Company), entered into an asset purchase agreement (the Agrmt) and closed the transactions contemplated therein with DeRoya...

S2 - 2025-03-05 8-K Item 1.01 Entry into a Material Definitive Agrmt.

As previously reported, on January 1, 2025, Predictive Oncology Inc. a Delaware corporation ( Predictive Oncology ), entered into binding letter of intent (the LOI ) with Renovaro, Inc., a Delaware corporation ( Renovaro ), ...

S3 - 2025-02-19 8-K Item 1.01. Entry into a Material Definitive Agrmt.

On February 18, 2025, Predictive Oncology Inc. (POAI or the Company) entered into a Securities Purchase Agrmt (the Purchase Agrmt) with several institutional and accredited investors for the sale by the Company of 3...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

POAI_OUT_17 [2025-03-25 07:40:59 -0400] 1038 Bytes | 227 tokens | Cum: 3161 tkns (39.51% of 8k)
==========================================================================

Showing S1 (chunk 1 of 3): S1:
Item 1.01. Entry into a Material Definitive Agreement.

On March 14, 2025, Predictive Oncology Inc. a Delaware corporation (Predictive Oncology or the Company), entered into an asset purchase agreement (the Agreement) and closed the transactions contemplated therein with DeRoyal Industries, Inc., a Tennessee corporation (DeRoyal), to sell and assign to DeRoyal assets and liabilities exclusively related to the business of providing products for automated, direct-to-drain medical fluid disposal, including the Companys STREAMWAY product line (the Business). These assets were operated by the Companys wholly owned subsidiary, Skyline Medical Inc. (Skyline Medical) and were reported in the Companys Eagan reportable operating segment in its quarterly and annual filings.

The purchased assets exclusively related to the business of providing products for automated, direct-to-drain medical

-- More of this article? (say: MOR) or Next section? (say: NEX) (only 3 chars. - please don't summarize yet)

POAI_OUT_19 [2025-03-25 07:41:17 -0400] 4313 Bytes | 1232 tokens | Cum: 4510 tkns (56.38% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+-------------------+----------------------+----------------------+------------------------+------------------------+-------------------------+
| Volume: 36,087 | SMA50: -16.77% | Market Cap: 8.04M | Option/Short: No / Yes | Sales past 5Y: 6.59% | Sales Surprise: -30.86% |
+-------------------+----------------------+----------------------+------------------------+------------------------+-------------------------+
| Avg Volume: 2.20M | SMA200: 9.14% | Shs Outstand: 7.21M | Short Float: 7.22% | Employees: 34 | EPS Surprise: -50.00% |
+-------------------+----------------------+----------------------+------------------------+------------------------+-------------------------+
| Rel Volume: 0.02 | Perf Week: -3.88% | Shs Float: 7.10M | Short Ratio: 0.23 | Debt/Eq: 1.22 | P/E: - |
+-------------------+----------------------+----------------------+------------------------+------------------------+-------------------------+
| RSI (14): 41.64 | Perf Month: -23.10% | Inst Own: 3.34% | Short Interest: 0.51M | Sales Y/Y TTM: -23.75% | Earnings: Nov 13 BMO |
+-------------------+----------------------+----------------------+------------------------+------------------------+-------------------------+
| ATR (14): 0.11 | Perf Quarter: 52.74% | Insider Own: 1.47% | Beta: 1.26 | ROE: -193.25% | |
+-------------------+----------------------+----------------------+------------------------+------------------------+-------------------------+
| SMA20: -6.99% | Index: - | Insider Trans: 0.00% | Sales Q/Q: -51.66% | ROI: -380.51% | |
+-------------------+----------------------+----------------------+------------------------+------------------------+-------------------------+

The next section covers any insider trading.
If this section may be blank due to no recent filings.

[Company Financial Summary]
[Company Details]
Name: Predictive Oncology Inc. Common Stock
Market Cap: 8038816.615
Shares Outstanding: 7209701
Sector: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 345686, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -3094690.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 1.115
Average Volume: 134909.0
30-Day High: 1.42
30-Day Low: 1.07

[Detailed Financials: Q3 2024]
- Total Assets: $7,498,234.0
- Total Liabilities: $5,531,265.0
- Total Equity: $1,966,969.0
- Current Assets: $4,567,408.0
- Current Liabilities: $3,816,766.0

[Income Statement: Q3 2024]
- Revenue: $345,686.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -0.48

[Cash Flow Statement: Q3 2024]
- Net Cash Flow: $-2,252,815.0

[Detailed Financials: Q2 2024]
- Total Assets: $10,587,126.0
- Total Liabilities: $6,493,155.0
- Total Equity: $4,093,971.0
- Current Assets: $6,884,749.0
- Current Liabilities: $4,618,511.0

[Income Statement: Q2 2024]
- Revenue: $278,722.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): -0.68

[Cash Flow Statement: Q2 2024]
- Net Cash Flow: $134,535
==== END OF FINANCIAL REPORT ====

You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.

Now, complete this report with the following:

1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]

1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

POAI_OUT_21 [2025-03-25 07:41:21 -0400] 676 Bytes | 167 tokens | Cum: 4911 tkns (61.39% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)

POAI_IN_23 [2025-03-25 07:41:22 -0400] 126 Bytes | 29 tokens | Cum: 5007 tkns (62.59% of 8k)
==========================================================================

====================================
[2025-03-25 04:41:22] # Analysis Completed
Elapsed Time: 61.16 seconds